BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2170973)

  • 21. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
    Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature.
    Bombí JA; Martínez A; Ramírez J; Grau JJ; Nadal A; Fernández PL; Palacín A; Cardesa A
    Ultrastruct Pathol; 2002; 26(4):211-8. PubMed ID: 12227946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
    Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
    Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas.
    Lantuéjoul S; Laverrière MH; Sturm N; Moro D; Frey G; Brambilla C; Brambilla E
    Hum Pathol; 2000 Apr; 31(4):415-21. PubMed ID: 10821486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytologic, histologic and electron microscopic correlations in poorly differentiated primary lung carcinoma. A study of 43 cases.
    Mennemeyer R; Hammar SP; Bauermeister DE; Wheelis RF; Jones HW; Bartha M
    Acta Cytol; 1979; 23(4):297-302. PubMed ID: 231365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
    Chetty R
    Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers.
    Kulshrestha R; Vijayan VK
    Indian J Chest Dis Allied Sci; 2009; 51(1):21-5. PubMed ID: 19317359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent differentiation in neuroendocrine lung tumors.
    Brambilla E; Lantuejoul S; Sturm N
    Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
    Mucci NR; Akdas G; Manely S; Rubin MA
    Hum Pathol; 2000 Apr; 31(4):406-14. PubMed ID: 10821485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
    van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
    Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
    Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
    Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of cluster 1 small cell lung cancer antigen and chromogranin A in lung carcinomas.
    Noguchi M; Hirohashi S; Shimosato Y
    Jpn J Clin Oncol; 1992 Feb; 22(1):6-9. PubMed ID: 1315401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
    Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
    Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.
    Gould VE; Jansson DS; Molenaar WM; Rorke LB; Trojanowski JQ; Lee VM; Packer RJ; Franke WW
    Lab Invest; 1990 Apr; 62(4):498-509. PubMed ID: 2159086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stainability of lung cancer cells with Leu-7 and OKT-9 monoclonal antibodies.
    Sato Y; Watanabe S; Kodama T; Goto M; Shimosato Y
    Jpn J Clin Oncol; 1985 Sep; 15(3):537-44. PubMed ID: 2414490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
    Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Do pathologic-anatomic data influence the staging of non-small cell bronchial cancer?].
    Brambilla E
    Rev Mal Respir; 1992; 9 Suppl 4():R309-15. PubMed ID: 1336879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
    Banks-Schlegel SP; Gazdar AF; Harris CC
    Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.